Purchase Order 75N91020P00700

<p>The National Institute on Aging awarded a purchase order to Research and Diagnostic Systems, Inc. for custom array service on June 1, 2020, with a ceiling value of $10,200.00 and an ultimate completion date of July 10, 2020. Work is performed in Minneapolis, Minnesota. No set-aside category was used; this was an open competition purchase order using firm fixed price terms.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,418 purchase order to the Regents of the University of Minnesota doing business as Office of Sponsored Projects Administration. The firm fixed price contract is for laboratory testing services and will be performed in Minneapolis, Minnesota over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,382.50 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The order is for ELISPOT KITS to be delivered between August 21, 2023 and September 20, 2023. The National Cancer Institute conducts and supports research into the causes, prevention, diagnosis, and treatment of cancer through its various programs and divisions. No set aside...

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...

<p>The National Cancer Institute awarded a purchase order to Advanced Cell Diagnostics, Inc. valued at $13,814.40 on September 17, 2020, with completion targeted for November 26, 2020. The order carries firm fixed pricing with no small business set-aside. Performance occurs in Newark, California. The purchase order procures RNA detection technologies and related diagnostic products from Advanced Cell Diagnostics' RNAscope platform for cancer research support.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>

<p>The National Cancer Institute awarded a purchase order to Irepertoire Inc. for $16,300 on September 21, 2020, with completion by October 30, 2020. The order is firm fixed price with no set-aside. Performance takes place in Huntsville, Alabama. The contractor will extract RNA, prepare cDNA, and sequence T-cell receptors from different mouse strains using multiplex PCR technology to quantitatively amplify cDNA of each T-cell receptor in provided tissue samples.</p>

<p>The National Cancer Institute awarded a purchase order to Proteinsimple valued at $5,000.00 on March 29, 2016, for de-obligation of expiring FY2016 funds. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of April 8, 2016.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Research And Diagnostic Systems, Inc. for a variety of antibodies valued at $34,920.35, effective September 20, 2018, with completion targeted for September 20, 2019. Place of performance is Minneapolis, Minnesota. The order was issued under open competition with no set-aside applied, following a solicitation posted August 13, 2018 and due August 22, 2018.</p>